The COVID-19 and Cancer Consortium (CCC19) published new findings in the Annals of Oncology, showing heightened mortality and racial disparities for patients with cancer diagnosed with SARS-CoV-2 infection. After reviewing detailed information from almost 5,000 patients with active or past cancer and laboratory-confirmed COVID-19 diagnosis, CCC19 study authors found associations among laboratory measures, clinical factors – including older age, haematological malignancy and recent chemotherapy – and poor clinical outcomes. Of the patients in the study with COVID-19 and cancer, 58% required hospitalisation and 14% died within 30 days – compared with a COVID-19 death rate below 2% for the general population.…